About 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole
4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole (PubChem CID 141135912) has the molecular formula C13H8N10O2
and a molecular weight of 336.28 g/mol. Its IUPAC name is 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole.
Molecular Properties
| Compound Name | 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole |
| PubChem CID | 141135912 |
| Molecular Formula | C13H8N10O2 |
| Molecular Weight | 336.28 g/mol |
| Exact Mass | 336.08 |
| IUPAC Name | 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole |
| SMILES | c1c[nH]c(-c2nn(-c3nn[nH]n3)c(-c3ncco3)c2-c2conn2)c1 |
| InChI | InChI=1S/C13H8N10O2/c1-2-7(14-3-1)10-9(8-6-25-22-16-8)11(12-15-4-5-24-12)23(19-10)13-17-20-21-18-13/h1-6,14H,(H,17,18,20,21) |
| InChIKey | OLRMXAVLKCNGPO-UHFFFAOYSA-N |
| XLogP | 1.09 |
| TPSA | 153.02 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 336.28 |
| LogP ≤ 5 | 1.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Analyze 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole?
The IUPAC name of 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole (CID 141135912) is 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole.
What is the SMILES notation for 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole?
The canonical SMILES for 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole is c1c[nH]c(-c2nn(-c3nn[nH]n3)c(-c3ncco3)c2-c2conn2)c1.
What is the InChIKey of 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole?
The InChIKey is OLRMXAVLKCNGPO-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H8N10O2/c1-2-7(14-3-1)10-9(8-6-25-22-16-8)11(12-15-4-5-24-12)23(19-10)13-17-20-21-18-13/h1-6,14H,(H,17,18,20,21).
What are the key properties of 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole?
4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole has a molecular weight of 336.28 g/mol, XLogP of 1.09, 4 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(1,3-oxazol-2-yl)-3-(1H-pyrrol-2-yl)-1-(2H-tetrazol-5-yl)pyrazol-4-yl]oxadiazole is sourced from PubChem (CID 141135912), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).